Abstract
Cardiac function in patients with acute respiratory distress syndrome (ARDS) is influenced by: (a) the severity of the lung injury; (b) the response of the lung destruction affecting the pulmonary circulation, which causes (c) an increase in the pulmonary vascular resistance and pulmonary hypertension; (d) the therapeutic maneuvers, positive end-expiratory pressure (PEEP) and pharmacological support; and (e) preexisting heart diseases such as coronary artery disease, cardiomyopathy, and myocarditis.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Brynjolf, I. (1987). A New Pharmacological Treatment of ARDS. In: Lawin, P. (eds) Aktuelle Aspekte und Trends der respiratorischen Therapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71300-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-71300-2_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-16651-1
Online ISBN: 978-3-642-71300-2
eBook Packages: Springer Book Archive